Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenyang Liu

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|July 7, 2022
Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung CancerXiaotong Lu, Jianyang Wang, Tao Zhang, et al.
Radiation Oncology (London, England)|February 4, 2022
Assessment and validation of the internal gross tumour volume of gastroesophageal junction cancer during simultaneous integrated boost radiotherapyJinming Shi, Yuan Tang, Ning Li, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 2023
Induction Immune Checkpoint Inhibitors and Chemotherapy Before Definitive Chemoradiation Therapy for Patients With Bulky Unresectable Stage III Non-Small Cell Lung CancerYu Wang, Tao Zhang, Jianyang Wang, et al.
Frontiers in Immunology|January 30, 2024
Induction PD-1 inhibitor toripalimab plus chemotherapy followed by concurrent chemoradiotherapy and consolidation toripalimab for bulky locally advanced non-small-cell lung cancer: protocol for a randomized phase II trial (InTRist study)Yu Wang, Lei Deng, Jianyang Wang, et al.
Thoracic Cancer|March 29, 2025
Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell CarcinomaCanjun Li, Xin Wang, Lei Deng, et al.
BMC Cancer|July 26, 2024
Hippocampal avoidance whole-brain radiotherapy with simultaneous integrated boost in lung cancer brain metastases and utility of the Hopkins verbal learning test for testing cognitive impairment in Chinese patients: a prospective phase II studyZhuoran Li, Jianyang Wang, Lei Deng, et al.
Medical Physics|January 12, 2017
Respiratory motion prediction and prospective correction for free-breathing arterial spin-labeled perfusion MRI of the kidneysHao Song, Dan Ruan, Wenyang Liu, et al.
Journal of Thoracic Disease|September 18, 2020
The impact of age on the survival outcomes and risk of radiation pneumonitis in patients with unresectable locally advanced non-small cell lung cancer receiving chemoradiotherapyTao Zhang, Nan Bi, Zongmei Zhou, et al.
BMC Cancer|August 10, 2018
A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancerNing Li, Xin Wang, Yuan Tang, et al.
Current Cancer Drug Targets|March 16, 2023
Efficacy and Safety of Concurrent Chemoradiotherapy Combined with Nimotuzumab in Elderly Patients with Esophageal Squamous Cell Carcinoma: A Prospective Real-world Pragmatic StudyNuo Yu, Guowei Cheng, Jiao Li, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|July 7, 2022
Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung CancerXiaotong Lu, Jianyang Wang, Tao Zhang, et al.
Radiation Oncology (London, England)|February 4, 2022
Assessment and validation of the internal gross tumour volume of gastroesophageal junction cancer during simultaneous integrated boost radiotherapyJinming Shi, Yuan Tang, Ning Li, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 2023
Induction Immune Checkpoint Inhibitors and Chemotherapy Before Definitive Chemoradiation Therapy for Patients With Bulky Unresectable Stage III Non-Small Cell Lung CancerYu Wang, Tao Zhang, Jianyang Wang, et al.
Frontiers in Immunology|January 30, 2024
Induction PD-1 inhibitor toripalimab plus chemotherapy followed by concurrent chemoradiotherapy and consolidation toripalimab for bulky locally advanced non-small-cell lung cancer: protocol for a randomized phase II trial (InTRist study)Yu Wang, Lei Deng, Jianyang Wang, et al.
Thoracic Cancer|March 29, 2025
Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell CarcinomaCanjun Li, Xin Wang, Lei Deng, et al.
BMC Cancer|July 26, 2024
Hippocampal avoidance whole-brain radiotherapy with simultaneous integrated boost in lung cancer brain metastases and utility of the Hopkins verbal learning test for testing cognitive impairment in Chinese patients: a prospective phase II studyZhuoran Li, Jianyang Wang, Lei Deng, et al.
Medical Physics|January 12, 2017
Respiratory motion prediction and prospective correction for free-breathing arterial spin-labeled perfusion MRI of the kidneysHao Song, Dan Ruan, Wenyang Liu, et al.
Journal of Thoracic Disease|September 18, 2020
The impact of age on the survival outcomes and risk of radiation pneumonitis in patients with unresectable locally advanced non-small cell lung cancer receiving chemoradiotherapyTao Zhang, Nan Bi, Zongmei Zhou, et al.
BMC Cancer|August 10, 2018
A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancerNing Li, Xin Wang, Yuan Tang, et al.
Current Cancer Drug Targets|March 16, 2023
Efficacy and Safety of Concurrent Chemoradiotherapy Combined with Nimotuzumab in Elderly Patients with Esophageal Squamous Cell Carcinoma: A Prospective Real-world Pragmatic StudyNuo Yu, Guowei Cheng, Jiao Li, et al.
Pageof 8